Ascent Wealth Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,000
| Closed | -$219K | – | 139 |
|
|
2018
Q4 | $219K | Hold |
3,000
| – | – | 0.09% | 111 |
|
|
2018
Q3 | $263K | Hold |
3,000
| – | – | 0.08% | 116 |
|
|
2018
Q2 | $295K | Hold |
3,000
| – | – | 0.1% | 104 |
|
|
2018
Q1 | $357K | Hold |
3,000
| – | – | 0.13% | 98 |
|
|
2017
Q4 | $381K | Hold |
3,000
| – | – | 0.14% | 98 |
|
|
2017
Q3 | $352K | Hold |
3,000
| – | – | 0.14% | 96 |
|
|
2017
Q2 | $239K | Sell |
3,000
-970
| -24% | -$77.3K | 0.1% | 108 |
|
|
2017
Q1 | $203K | Buy |
+3,970
| New | +$203K | 0.09% | 117 |
|